This T32 Training Grant has focused successfully over the past 25 years on providing a dynamic research training environment for pathologists, other physician-scientists and basic scientists working in molecular pathology. Over the past two 5-year funding periods, trainees have published a considerable number of papers, including in high quality journals, and have found faculty positions in prestigious medical schools. The present, proposed configuration of the grant features 20 Harvard Medical School faculty centered in the Molecular Pathology Unit and Cancer Center. This interactive, overlapping community of scientists and physician-scientists is organized into thematic programs in cancer genetics; animal models of cancer; signal transduction and oncogenesis; mechanisms of gene regulation; cell cycle control; hematopoiesis and stem cells; and immunobiology. The present proposal also incorporates important changes: a further focus toward cancer biology; a shift in faculty, reflecting participation during the prior funding period and scientific direction; an administrative reorganization to broaden scientific and mentoring input; and a request to increase from 5 to 7 training positions. As in previous cycles, the trainees will be selected from a competitive pool of MD, MD-PhD and PhD applicants on the basis of prior academic and research achievements and evidence of a strong commitment to a career in science. The period of training will be two or three years for each successful applicant. An active minority outreach approach ensures access to the training program by underrepresented minorities, as evidenced by a successful record (3 of 12 trainees in the past funding period were underrepresented minorities). In summary, the proposed T32 program renewal capitalizes on a highly interactive, experienced and focused faculty; a distinguished record of training productive physicians and scientists, including minorities; state-of-the-art facilities and educational resources; and exposure of the trainees to basic and translational aspects of cancer biology. ? ? ? ?
| Bester, Assaf C; Lee, Jonathan D; Chavez, Alejandro et al. (2018) An Integrated Genome-wide CRISPRa Approach to Functionalize lncRNAs in Drug Resistance. Cell 173:649-664.e20 |
| Guo, Xiaoge; Chavez, Alejandro; Tung, Angela et al. (2018) High-throughput creation and functional profiling of DNA sequence variant libraries using CRISPR-Cas9 in yeast. Nat Biotechnol 36:540-546 |
| Shostak, Eugene; Hariri, Lida P; Cheng, George Z et al. (2018) Needle-based Optical Coherence Tomography to Guide Transbronchial Lymph Node Biopsy. J Bronchology Interv Pulmonol 25:189-197 |
| Chavez, Alejandro; Pruitt, Benjamin W; Tuttle, Marcelle et al. (2018) Precise Cas9 targeting enables genomic mutation prevention. Proc Natl Acad Sci U S A 115:3669-3673 |
| Yeo, Nan Cher; Chavez, Alejandro; Lance-Byrne, Alissa et al. (2018) An enhanced CRISPR repressor for targeted mammalian gene regulation. Nat Methods 15:611-616 |
| Carey, Allison F; Rock, Jeremy M; Krieger, Inna V et al. (2018) TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities. PLoS Pathog 14:e1006939 |
| Masia, Ricard; McCarty, William J; Lahmann, Carolina et al. (2018) Live cell imaging of cytosolic NADH/NAD+ ratio in hepatocytes and liver slices. Am J Physiol Gastrointest Liver Physiol 314:G97-G108 |
| Shapiro, Rebecca S; Chavez, Alejandro; Porter, Caroline B M et al. (2018) A CRISPR-Cas9-based gene drive platform for genetic interaction analysis in Candida albicans. Nat Microbiol 3:73-82 |
| Mordes, Daniel A; Prudencio, Mercedes; Goodman, Lindsey D et al. (2018) Dipeptide repeat proteins activate a heat shock response found in C9ORF72-ALS/FTLD patients. Acta Neuropathol Commun 6:55 |
| Hariri, Lida P; Adams, David C; Wain, John C et al. (2018) Endobronchial Optical Coherence Tomography for Low-Risk Microscopic Assessment and Diagnosis of Idiopathic Pulmonary Fibrosis In Vivo. Am J Respir Crit Care Med 197:949-952 |
Showing the most recent 10 out of 130 publications
